RMTI · All filings · Read this filing

What changed 10-Q

Item 5. Other Information

2025-05-12 compared with 2024-11-12 · 6 added, 2 removed, 18 unchanged (31% of the section changed)

3 unchanged sentences

31.1* Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

31.2* Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

32.1** Certification pursuant to 18 U.S.C.

Section 1350 and Rule 13a-14(b) of the Securities Exchange Act of 1934

32.2** Certification pursuant to 18 U.S.C.

Section 1350 and Rule 13a-14(b) of the Securities Exchange Act of 1934

101.INS* XBRL Instance Document

9 unchanged sentences

ROCKWELL MEDICAL, INC.

November 12, 2024 /s/ Mark Strobeck

May 12, 2025 /s/ Mark Strobeck

Mark Strobeck, Ph.D.

Chief Executive Officer (Principal Executive Officer and Interim Financial Officer)

President, Chief Executive Officer and Director

(Principal Executive Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.